Justice Suspends Pharmacy Drug Sales
- BUENOS AIRES,Argentina (AP) — an Argentine court has temporarily blocked the sale of over-the-counter medications in establishments other than pharmacies,siding with pharmaceutical groups who argued that the move...
- The federal Administrative Chamber issued the ruling,suspending articles of Decree of Need and Urgency (DNU) 70/2023,enacted by the management of President Javier Milei.
- The argentine Pharmaceutical Confederation (COFA) and the Pharmaceutical Federation (Fefara) brought the case, contending that the decree violated labor and health regulations, posing a risk to the public.
Argentine Court Halts Sale of Over-the-Counter Drugs in Non-Pharmacies
BUENOS AIRES,Argentina (AP) — an Argentine court has temporarily blocked the sale of over-the-counter medications in establishments other than pharmacies,siding with pharmaceutical groups who argued that the move endangered public health and infringed on professional standards.
The federal Administrative Chamber issued the ruling,suspending articles of Decree of Need and Urgency (DNU) 70/2023,enacted by the management of President Javier Milei. The suspended articles had permitted the sale of non-prescription drugs in a wider range of retail outlets, including supermarkets and kiosks.
Pharmaceutical Groups Cite Health Risks
The argentine Pharmaceutical Confederation (COFA) and the Pharmaceutical Federation (Fefara) brought the case, contending that the decree violated labor and health regulations, posing a risk to the public. The court agreed, citing the need to protect public health and the professional practice of pharmacists.
The court’s decision emphasizes the importance of ensuring the safety and efficacy of medical treatments, arguing that sales in non-specialized businesses could compromise these standards.
Impact of the Ruling
The judicial decision has national reach,effectively reversing the deregulation outlined in DNU 70/2023 regarding over-the-counter drug sales in non-pharmacy settings. This restores the exclusivity of pharmacies in selling these products, as originally mandated by Law 17,565 of 1967.
Furthermore, the ruling suspends the relaxed regulations concerning the professional activities of pharmacists, which were also part of the Milei administration’s decree.
What’s Next?
The temporary suspension will remain in effect while the court further examines the case. The judiciary is expected to assess the constitutionality of DNU 70/2023 and its broader implications for the healthcare system and the pharmaceutical industry.
In the interim, pharmacies will maintain their exclusive role in dispensing over-the-counter medications, ensuring adherence to established health regulations and professional oversight.
The Associated Press contributed to this report.
Argentine Court Halts Sale of Over-the-counter Drugs in Non-Pharmacies: A Q&A
This article provides a comprehensive overview of a recent court decision in Argentina regarding the sale of over-the-counter (OTC) medications. It delves into the specifics of the ruling, its implications, and what’s likely to happen next.
What Happened in Argentina Regarding OTC Drug Sales?
An Argentine court has temporarily blocked the sale of over-the-counter medications in establishments other then pharmacies. This ruling, issued by the federal Administrative Chamber, suspended certain articles of Decree of Need and Urgency (DNU) 70/2023 enacted by President Javier Milei’s governance. These suspended articles had previously allowed for the sale of non-prescription drugs in a wider range of retail outlets, such as supermarkets and kiosks.
Why Did the Court Make This Decision?
The court sided with pharmaceutical groups, specifically the Argentine Pharmaceutical Confederation (COFA) and the Pharmaceutical Federation (Fefara). These groups argued that the deregulation of OTC drug sales endangered public health and infringed on professional standards. The court agreed, citing the importance of protecting public health and the professional practice of pharmacists. They emphasized the need to ensure the safety and efficacy of medical treatments, which they believe could be compromised by sales in non-specialized businesses.
What Were the Key Arguments Against the Decree?
the main arguments against Decree 70/2023, as presented by COFA and Fefara, were:
Violation of Labor and Health Regulations: The decree was seen as a violation of existing rules governing labor practices and healthcare standards.
Risk to Public Health: The pharmaceutical groups contended that allowing OTC drugs to be sold in a wider variety of locations posed a risk to the public.
Infringement on Professional Standards: Expanding sales beyond pharmacies was perceived as infringing on the professional practice of pharmacists, who are trained to provide guidance on medication use.
What is Decree of Need and Urgency (DNU) 70/2023?
Decree of Need and Urgency (DNU) 70/2023 was a measure enacted by the administration of President Javier Milei. It sought to deregulate various aspects of the Argentinian economy, including the healthcare sector. Regarding OTC medications,the decree aimed to broaden the range of establishments where these drugs could be sold.
what is the Impact of the court’s Ruling?
The court’s decision has a national reach and effectively reverses the deregulation outlined in DNU 70/2023 concerning OTC drug sales.
Restoration of Pharmacy Exclusivity: The ruling restores the exclusivity of pharmacies in selling OTC medications. This policy was originally mandated by Law 17,565 of 1967.
Suspension of Relaxed Regulations: The court also suspended the relaxed regulations concerning the professional activities of pharmacists, which were part of the original decree.
Were Any Existing Laws Referenced in the Ruling?
Yes, the court referenced Law 17,565 of 1967, which originally mandated that pharmacies have the exclusivity in selling OTC drugs. The court’s decision aims to return to the standards established by this law.
What’s Next for this Case?
The temporary suspension of the decree will remain in effect while the court further examines the case.
Examination of Constitutionality: The judiciary is expected to assess the constitutionality of DNU 70/2023.
Assessment of Broader Implications: The court will also consider the broader implications of the decree for the healthcare system and the pharmaceutical industry.
Interim Measures: Pharmacies will continue to maintain their exclusive role in dispensing OTC medications while the court deliberates, ensuring adherence to health regulations and professional oversight.
Who Contributed to This Report?
the information in this report was provided by the associated Press (AP), as stated at the end of the original article.
How Does This relate to Argentina’s Healthcare System?
The court’s decision highlights the ongoing debate about the regulation of the pharmaceutical